WallStreetZenWallStreetZen

NASDAQ: FENC
Fennec Pharmaceuticals Inc Stock Ownership - Who owns Fennec Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Fennec Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Robert AndradeCHIEF FINANCIAL OFFICER2026-01-2310,000$2.45
$24.50kBuy
Robert AndradeCHIEF FINANCIAL OFFICER2026-01-1510,000$2.45
$24.50kBuy
Robert AndradeCHIEF FINANCIAL OFFICER2026-01-0714,184$2.45
$34.75kBuy
Rosty RaykovDirector2026-01-0215,598$2.45
$38.22kBuy
Rosty RaykovDirector2026-01-0210,312$7.60
$78.37kSell
Southpoint Capital Advisors LP10% Owner2025-12-241,000,000$7.50
$7.50MSell
Rosty RaykovDirector2025-12-0510,000$7.54
$75.40kSell
Southpoint Capital Advisors LP10% Owner2025-11-1819,341$8.79
$170.05kSell
Southpoint Capital Advisors LP10% Owner2025-11-1785,918$8.79
$755.22kSell
Southpoint Capital Advisors LP10% Owner2025-11-14160,100$8.00
$1.28MSell

1 of 4

FENC insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when FENC insiders and whales buy or sell their stock.

FENC Shareholders

What type of owners hold Fennec Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Southpoint Capital Advisors LP721.08%202,744,741$1.54BInsider
Robert W. Butts442.84%124,512,000$945.05MInsider
Southpoint Capital Advisors LP14.50%4,077,214$30.95MInstitution
Southpoint Master Fund LP14.22%3,997,214$30.34MInsider
Spa Essetifin14.20%3,993,694$30.31MInsider
Solas Capital Management LLC7.78%2,187,902$16.61MInstitution
Manchester Management Pr LLC7.77%2,184,023$16.58MInsider
Manchester Management Co LLC7.77%2,184,023$16.58MInsider
Rosalind Advisors Inc7.39%2,076,840$15.76MInstitution
William G. Breen4.86%1,367,781$10.38MInsider

1 of 3

FENC vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
FENC3.88%96.12%Net SellingNet Selling
ARCT87.51%12.49%Net Buying
TNXP13.29%86.71%Net Buying
VYGR50.66%49.34%Net Selling
SABS35.08%64.92%Net Buying
View Top Biotech Stocks

Fennec Pharmaceuticals Stock Ownership FAQ

Who owns Fennec Pharmaceuticals?

Fennec Pharmaceuticals (NASDAQ: FENC) is owned by 49.31% institutional shareholders, 1,220.52% Fennec Pharmaceuticals insiders, and 0.00% retail investors. Southpoint Capital Advisors LP is the largest individual Fennec Pharmaceuticals shareholder, owning 202.74M shares representing 721.08% of the company. Southpoint Capital Advisors LP's Fennec Pharmaceuticals shares are currently valued at $1.54B.

If you're new to stock investing, here's how to buy Fennec Pharmaceuticals stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.